Skip to main content

Table 2 Changes in the levels of various enzymatic and biochemical parameters of the serum samples of seven experimental groups. Data represented as mean ± SD of six observations

From: Haloalkane induced hepatic insult in murine model: amelioration by Oleander through antioxidant and anti-inflammatory activities, an in vitro and in vivo study

 

Control

CCl4

Silymarin

NOSE low

NOSE high

NORE low

NORE high

ACP (K.A.)

3.61 ± 0.31

10.94 ± 1.04***

5.76 ± 0.43** b

10.01 ± 0.61*** d

8.75 ± 0.44*** c

9.64 ± 0.31*** d

8.55 ± 0.32*** c

ALP (K.A.)

10.86 ± 1.29

28.44 ± 1.25***

12.93 ± 0.80NS a

24.92 ± 2.27*** d

22.21 ± 2.45** a

24.56 ± 0.95*** c

22.10 ± 1.45*** b

AST (U/ml)

65.88 ± 3.74

137.28 ± 2.95***

74.01 ± 0.16NS a

121.27 ± 2.89*** a

99.19 ± 5.48*** b

117.93 ± 6.30*** b

110.25 ± 5.00*** b

ALT (U/ml)

42.63 ± 1.4

126.26 ± 4.88***

53.81 ± 3.15** a

109.27 ± 4.21*** c

81.27 ± 7.66** d

119.23 ± 6.40*** d

95.94 ± 10.39*** c

GGT (U/l)

2.51 ± 0.36

6.06 ± 0.23***

3.35 ± 0.12* a

5.48 ± 0.33*** d

4.9 ± 0.36** c

5.5 ± 0.25*** c

4.48 ± 0.24** b

Glucose (mg/dl)

53.53 ± 1.28

80.38 ± 1.55***

55.23 ± 3.48NS a

76.40 ± 4.71** d

63.39 ± 1.42*** a

74.96 ± 2.95*** c

65.86 ± 3.43** b

Protein (g/dl)

4.77 ± 0.29

3.10 ± 0.23**

4.94 ± 0.05NS a

3.29 ± 0.21** d

4.19 ± 0.24NS b

3.62 ± 0.13** c

3.88 ± 0.07** b

Albumin (g/dl)

3.18 ± 0.07

1.42 ± 0.13***

2.86 ± 0.17* a

1.53 ± 0.27*** d

1.96 ± 0.22*** a

1.55 ± 0.09*** NS

1.71 ± 0.26*** NS

Globulin (g/dl)

1.59 ± 0.30

1.68 ± 0.12NS

2.11 ± 0.17NS c

1.76 ± 0.28NS d

2.23 ± 0.03* b

2.06 ± 0.12NS c

2.17 ± 0.20NS c

Bilirubin (mg/dl)

0.41 ± 0.03

1.15 ± 0.04***

0.51 ± 0.02* a

1.01 ± 0.03*** b

0.91 ± 0.06*** b

1.11 ± 0.07*** d

1.01 ± 0.02*** b

Urea (mg/dl)

20.58 ± 2.39

111.84 ± 3.54***

35.25 ± 6.78* a

106.83 ± 3.23*** d

75.67 ± 5.59*** a

89.96 ± 3.77*** b

67.71 ± 7.43*** a

LDH (U/l)

219.16 ± 7.19

526.97 ± 7.97***

288.44 ± 10.99*** a

511.31 ± 6.73*** d

433.8 ± 17.47*** b

495.13 ± 12.21*** c

472.24 ± 12.07*** b

Cholesterol (mg/dl)

78.86 ± 3.49

134.52 ± 0.78***

105.62 ± 3.36*** a

122.00 ± 5.39*** a

114.62 ± 5.39*** b

124.96 ± 5.38 *** d

113.48 ± 6.80** b

  1. NSp = non-significant (p > 0.05), *p < 0.05, **p < 0.01 and ***p < 0.001 vs control
  2. dp = non-significant (p > 0.05), c p < 0.05, b p < 0.01 and a p < 0.001 vs CCl4 group